Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Devex Newswire: US Congress Defies Trump with $600M for Family Planning
U.S. Congress approved a $600 million carve‑out for family planning and reproductive health within a broader $50 billion foreign‑affairs package, directly contradicting President Trump’s anti‑abortion agenda. The administration’s expanded Mexico City Policy and withdrawal from UN women agencies raise doubts about whether the funds will ever be released. Simultaneously, gender‑focused investment initiatives face a funding vacuum as U.S. support wanes, while European development banks and private actors continue to back women‑empowerment projects. Development professionals are also pivoting to mission‑driven roles outside traditional aid agencies.
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis commissioned Datos Insights to survey over 2,200 health‑plan executives, employer‑benefits leaders and insured consumers, revealing mounting financial pressure across the healthcare ecosystem. The study shows that 63% of employers view price transparency as a key cost‑management tool, while 68%...
Federal Judge Blocks Kennedy Changes to Childhood Vaccine Schedule; BANG
A federal judge issued a temporary injunction blocking Secretary Kennedy's revisions to the childhood vaccine schedule and halting new appointments to the CDC’s vaccine advisory committee. The administration had re‑categorized six vaccines under a novel "parental‑choice" framework, prompting legal challenges. Kennedy’s...
Huntington’s Disease Gene Therapy: FDA Reversal Delays AMT-130
A Phase I/II trial of AMT‑130, an AAV‑delivered microRNA gene therapy, showed a 75% reduction in Huntington's disease progression over three years in 12 patients. The FDA initially supported using external control data from the Enroll‑HD database for the Biologics...
Cooper University Health Care’s Curran Says Cross-Functional Collaboration Was the Key to Securing More Than 10,000 Edge Devices
Cooper University Health Care completed an 18‑month program that lifted device visibility from 25 percent to 100 percent across more than 10,000 IoT and medical devices. The effort relied on passive network‑monitoring tools, rigorous network segmentation, and a new security‑by‑procurement framework. A...
NYU Langone Health’s O’Brien & Major Explain Keys to Effective Nursing/AI Partnership
NYU Langone Health has built a structured partnership between nursing informatics and data science that fuels AI tool development and adoption. Since 2019, the collaboration has produced decision‑support models, a pressure‑injury prevention system, and a fall‑prediction tool, all vetted through...
Northwestern Medicine’s Sama Says AI Optimization Requires a New Data Foundation
During HIMSS 2026, Northwestern Medicine’s VP Danny Sama warned that health‑system AI initiatives are outpacing investment in core data infrastructure. He noted that roughly 80 percent of effort is spent on AI while the underlying data plumbing remains underfunded, exposing technical debt....
New York-Presbyterian’s Linsangan Says Live Simulations Expose What Tabletop Exercises Miss
New York‑Presbyterian launched live downtime simulations across its ten hospitals after a cyberattack at a peer institution highlighted systemic vulnerabilities. The exercises, run during peak daytime hours on real patient scenarios, revealed that many clinicians lacked paper‑charting experience, struggled with medication...
Is GLP-1 Itch Something to Be Concerned About?
Recent reports and media coverage highlight itchy skin as a newly recognized side effect of GLP‑1 agonists such as semaglutide (Ozempic, Wegovy). Dermatology and weight‑loss specialists say the symptom is uncommon but has been observed, particularly among patients experiencing rapid...
AstraZeneca Secures the EC Approval of Imfinzi as a Perioperative Therapy for G/GEJ Cancers
The European Commission has granted approval for AstraZeneca’s Imfinzi (durvalumab) combined with FLOT chemotherapy as a perioperative treatment for resectable, early‑stage and locally advanced gastric and gastro‑esophageal junction (G/GEJ) cancers. The decision is based on the Phase III MATTERHORN trial, which...
GEN Secures BEBO Foundation Approval for Phase II PD Trial
GEN Pharmaceuticals received BEBO Foundation ethical approval to launch a Phase II proof‑of‑concept trial of its mitochondrial‑targeting drug SUL‑238 in Parkinson’s disease. The single‑centre, randomised, double‑blind, placebo‑controlled study, named SHEPHERD, will begin patient enrolment in Groningen in April 2026. Over a 28‑day...
What the Evolving Microbial Nomenclature Means for the Clinical Microbiology Lab
Rapid advances in whole‑genome sequencing are prompting frequent revisions to microbial taxonomy and nomenclature, creating operational challenges for clinical microbiology labs. While some updates—such as recognizing Staphylococcus pseudintermedius—enhance antimicrobial‑resistance insight and enable species‑specific susceptibility breakpoints, other changes driven mainly by...
I'm Concerned About My Blood Pressure. Can I Check It at Home?
Hypertension affects about 31 % of adults worldwide, and a single office reading often fails to capture true blood‑pressure trends due to stress and white‑coat effects. The American College of Cardiology now recommends home monitoring to supplement annual screenings, providing multiple...
I Had to Man up and Get a Mammogram
A man with a BRCA1 mutation underwent his first mammogram, discovering that the procedure is virtually identical for men and women. The article highlights the rarity of male breast cancer—about 1 in 726 men—but notes that genetic risk and family...
Maine Could Determine Abortion Rights for the Nation. Why Aren’t Reproductive Rights Groups Acting Accordingly?
Maine’s 2026 Senate race has become a bellwether for the Democratic quest to regain a Senate majority, with Governor Janet Mills positioning herself as the party’s most viable challenger to incumbent Susan Collins. Reproductive‑rights groups such as EMILY’s List and...
Death Returns From Holiday
In a candid essay, infectious‑disease specialist Dr. Mark Crislip recounts his career‑long exposure to death from infections and uses those memories to warn that recent U.S. policy cuts to USAID and vaccination programs could trigger millions of preventable fatalities. He cites...
867-5309: Number From 1980s Hit Song Jenny Now Routes Callers to Cancer Support
Tommy Tutone’s iconic phone number 867‑5309 is being rerouted to the Cancer Support Community’s helpline, providing free counseling and resources to patients and caregivers. The campaign, launched in partnership with Gilda’s Club, leverages the cultural cachet of the 1980s hit...
Reaching for Workflow Efficiencies in Urinalysis
A CAP TODAY roundtable examined how artificial intelligence can streamline urinalysis workflow, particularly through AI‑driven reflex testing that merges urine chemistry and microscopy results with electronic health‑record data. Participants from Sysmex America and Beckman Coulter noted that adoption has been gradual...
Gavi Warns of Six Threats that Could Shape Global Health This Year
Gavi’s 2026 health outlook flags six converging threats—conflict‑driven displacement, climate‑fueled mosquito‑borne disease, a collapse in global health financing, rampant misinformation, the emerging Marburg virus, and the looming “Disease X.” The United States’ 2025 aid freeze left Kenya without 41,500 community health...
Reproductive Health Clinics Scramble as Title X Funding Cliff Approaches
A coalition of 128 Democratic lawmakers has urged the Health and Human Services Department to grant a one‑year extension for Title X funding as the program faces a March 31 deadline. HHS missed its Dec 31 guidance deadline, opening grant applications with only...
Lost in Transmission: Changes in Organ Donor Status Can Fall Through Cracks in the System
The article highlights a systemic gap in U.S. organ donation where a donor’s later “no” can be overridden by an earlier “yes” from another state, as illustrated by the case of Raven Kinser. State‑based donor registries and the private, federally...
STAT+: White House Digs in on ‘Most-Favored Nation’ Drug Pricing Despite Congress’ Cool Reception
The White House is intensifying pressure on Congress to pass a “most‑favored nation” drug‑pricing bill that would cap U.S. medication prices at levels paid by peer nations. Administration officials say the proposal would overhaul pricing for providers, insurers, federal programs...
Revolutionizing Data Capture Through Integrated Patient Experience Platforms
Clinical trials are adopting integrated eCOA platforms that connect medical devices directly to digital systems, eliminating manual data entry and improving data quality. Interoperability enables real‑time monitoring and AI‑driven insights, reducing patient burden especially in long‑duration obesity studies. The obesity...
Colliding Currents Can Target the Deep Brain without Surgery
Temporal interference (TI) stimulation uses two high‑frequency electrical currents that intersect to generate a low‑frequency envelope capable of modulating deep‑brain activity without surgery. Early human pilots have reported seizure suppression and better sleep in epilepsy, improved motor learning after stroke,...
Attacks on Hospitals Are Surging in War Zones. What Do the Laws of War Say About Protecting Them?
Attacks on hospitals have surged worldwide, with the WHO confirming 27 strikes in Lebanon alone and MSF reporting 1,348 incidents in 2025, double the previous year. High‑profile cases include a Pakistani airstrike on a Kabul drug‑rehab centre and an Israeli...
OBBBA: From Compliance Crisis to Digital Transformation Catalyst
The One Big Beautiful Bill Act (OBBBA) introduces sweeping reforms that will reshape how Americans access and pay for health care through 2028. New mandates, such as semi‑annual Medicaid eligibility checks, force providers to adopt automation and AI to maintain...
Alliance CEO Criticizes MedPAC’s ‘Misguided’ 7% Home Health Payment Cut Recommendation
The Medicare Payment Advisory Commission (MedPAC) has recommended a 7% reduction in the Medicare fee‑for‑service home health payment rate for 2027, projecting $750 million in savings in the first year and up to five‑year cumulative cuts. The National Alliance for Care...
Stress-Testing Proposals to Add Autism to the VICP
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is steering a push to expand the National Vaccine Injury Compensation Program (VICP) to cover autism spectrum disorder claims. Recent actions include a proposal to amend the VICP Injury Table,...
Dilated Vs. Hypertrophic Cardiomyopathy: What’s the Difference?
Dilated cardiomyopathy (DCM) weakens and thins the left‑ventricular wall, causing the heart to enlarge, while hypertrophic cardiomyopathy (HCM) thickens that wall and can obstruct blood flow. Both conditions present with similar symptoms—shortness of breath, fatigue, chest pain—but their underlying mechanisms...
What To Know About Breast Cancer Recurrence
Early‑stage breast cancer patients face a lingering concern about recurrence, which can be local, regional, or distant. Dr. Margaret Thompson explains that recurrence rates have fallen over the past two decades thanks to improved surgery, radiation, and systemic therapies. Individual...
When To Take Your Baby to the Hospital for RSV
Respiratory syncytial virus (RSV) commonly presents as a cold in infants, but babies under six months can develop bronchiolitis that quickly impairs breathing. Pediatrician Dr. Kristin Barrett advises parents to monitor peak symptom days (days 3‑5) and watch for red‑flag...
Leucovorin, Long-Read Sequencing, and More
Leucovorin prescriptions for autistic children jumped 71% after a White House briefing promoted the drug, yet the FDA only approved it for cerebral folate deficiency and withdrew any autism claim. A 2024 autism trial supporting leucovorin was retracted, casting doubt...
Women Pay $4,700 Extra Yearly for Hidden Health Costs
Women spend an estimated $4,700 more per year in out-of-pocket healthcare costs than men, for conditions that often go undiagnosed for a decade. Who built this system and who did they build it for?
Australia’s New Physical Activity Guidelines Won’t Shift the Needle – Here Are 4 Better Ideas
Australia released its first 24‑hour movement guidelines for adults, adding sleep recommendations and step targets. The guidance emphasizes 7‑9 hours of quality sleep and 7,000 daily steps but stops at advice without funding or regulatory changes. Critics argue that without...
Clinical AI Gains Ground in a Resource-Constrained Hospital
San Juan Regional Medical Center, a rural hospital serving the Four Corners region, has implemented Wellsheet, a clinical AI platform that embeds UpToDate evidence directly into the electronic health record. The adoption, launched in January 2026, is driven by chronic...
Global Resource Developed for Osteoporosis Self Management
The International Osteoporosis Foundation has launched Build Better Bones, a multilingual, user‑centered website that supports self‑management for people with osteoporosis and their caregivers. Developed through design‑thinking and agile methods, the platform offers evidence‑based guidance on exercise, nutrition, home safety, and...
NeuroScientific Readies Stem Cell Supply Boost for Bowel Disease Trials
NeuroScientific Biopharmaceuticals has begun its first manufacturing run of the StemSmart mesenchymal stem cell therapy at Q‑Gen Cell Therapeutics in Brisbane, initiating a critical technology transfer. The engineering run will validate quality, potency and regulatory compliance ahead of a Phase 2...
Combine GLP‑1 Drugs with Better Sleep for Optimal Health
An estimated 30 million Americans have obstructive sleep apnea. GLP-1 medications are producing weight loss at a scale we haven’t seen before. A 20% loss makes apnea 53% less severe. Something that doesn’t get enough attention: sleep is a metabolic intervention....
R1 Secures $78M to Advance Kidney Drug Development
R1 starts up with $78M, aiming for a better kidney drug https://t.co/PQQjX47ODM by @gwendolynawu #biotecjh #startups
Abeona Therapeutics Inc (ABEO) Q4 2025 Earnings Call Transcript
Abeona Therapeutics reported its Q4 2018 results, highlighting progress on its lead cell therapy EB-101 for recessive dystrophic epidermolysis bullosa (RDEB). The Phase 1/2 trial demonstrated continuous type VII collagen expression for over two years, a favorable safety profile, and durable wound...
New Drug Could Eradicate Sleeping Sickness, Says NPR
Sleeping sickness could be wiped out with this new drug: my comments @NPR @NPRGlobalHealth https://t.co/T0mAeX8P0A
Forgotten Victims: Forced Sterilizations in India Ignored
Where's the obituary for the millions of poor Indians who were forcibly sterilized by international programs directly inspires by Ehrlich's work? Or would that story be "premature"?
Healthequity Inc (HQY) Q4 2026 Earnings Call Transcript
HealthEquity posted a strong Q1 FY2026, with revenue climbing 15% year‑over‑year to roughly $1.1 billion and adjusted EBITDA rising 19% to $140.2 million, pushing the EBITDA margin to 42%. HSA assets surged 15% to $31 billion, driven by a 16% jump in investing...
Women Comprise Two‑thirds of Alzheimer’s; Midlife Origins Examined
Why do women account for nearly 2/3rd of all cases of Alzheimer's disease? A new, thorough review @jclinicalinvest, open-access, on its origins in midlife. https://t.co/obITwhEiYG https://t.co/RXBffM9jKV
Pacific Health Care Organization Inc (PFHO) Q4 2025 Earnings Call Transcript
Pacific Health Care Organization (PFHO) reported record Q4 2025 results, with health‑plan membership rising 25% to 236,300 and total revenue climbing 46% to $3.9 billion. Adjusted EBITDA surged from $1 million in 2024 to $110 million, delivering a 2.8% margin and an MBR...
Longeveron Inc (LGVN) Q4 2025 Earnings Call Transcript
Geron reported full‑year 2025 net revenue of $184 million from Rytelo, with Q4 sales of $48 million, and projected 2026 revenue of $220‑240 million. Operating expenses are expected to fall to $230‑240 million, reflecting lower R&D spend and modest SGA reductions after a restructuring....
Behavioral Health Law Ledger | March 2026
The Office of the Assistant Secretary for Technology Policy and the ONC launched nine pilot programs across nine jurisdictions, involving 45 organizations, to test behavioral health data‑exchange standards using the USCDI+ dataset and FHIR profiles, backed by roughly $20 million from...
How FDA Can Better Align Its Draft Guidance on Flavored ENDS with the Tobacco Control Act’s APPH Mandate
The FDA released draft guidance on flavored electronic nicotine delivery systems (ENDS) that seeks to clarify evidentiary expectations for pre‑market tobacco product applications. The article argues the guidance should better reflect Section 910 of the Tobacco Control Act, which requires an...
Chronilogix Announces Safety-First AI Architecture for Mental Health and Chronic Care Coaching
Chronologix unveiled a safety-first AI architecture designed for mental health and chronic care coaching. The platform embeds multi‑layered guardrails that monitor user behavior, detect distress signals, and trigger escalation to professional resources. It deliberately avoids providing medical diagnoses, focusing instead...
No Evidence to Suggest Medicinal Cannabis Is Effective for Depression, Anxiety or PTSD, Says Systematic Review
A systematic review published in Lancet Psychiatry, analysing 54 randomized controlled trials from 1980‑2025, found no evidence that medicinal cannabis treats depression, anxiety or PTSD. The paper highlights modest benefits for conditions such as epilepsy, multiple sclerosis spasticity, pain and...